ABOUT US

ZHONGCHAO INC. (NasdaqCM: ZCMD)

Zhongchao Inc. a holding company incorporated under the laws of the Cayman Islands, through its variable interest entity and subsidiaries, provides healthcare information, education, and training services to healthcare professionals and the public in China. The Company commenced its operation, through Zhongchao Shanghai, in August 2012 with a vision to offer a wide range of accessible and immediate healthcare information and continuous learning and training opportunities for Chinese healthcare professionals.

More

Stock Chart
News
  • 01 Zhongchao Inc. Offers Advanced Workshops in Partnership with European Wound Management Association (EWMA)

    SHANGHAI, Aug. 21, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it continues to partner with European Wound Management Association ("EWMA") to offer advanced workshops on wound care and rehabilitation (the "Workshops") to physicians. The Workshops cover Wound Management Core Course and Wound Healing Advanced Course, both of which are part of the EWMA Curriculums on Wound Healing for Physicians (the "EWMA Curriculums") and are exclusively licensed to Zhongchao in China. The Workshops are offered on-site only with each session typically taking 5 full days. Upon completion of a workshop session, participants are eligible to take a qualification exam and receive an EWMA certificate.

  • 02 Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease

    Shanghai, China, Aug. 11, 2020 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it has partnered with the China Association of Health Promotion and Education (the “CAHPE”) on developing live interactive programs/courses (the “Project”) aiming to promote and implement the Global Initiative for Chronic Obstructive Lung Disease (the “GOLD”) in China.

  • 03 Zhongchao Inc. Renews Contract with Johnson & Johnson (China) Limited, Extending the Cooperation sin

    SHANGHAI, Aug. 4, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced the renewal of contract with Johnson & Johnson (China) Limited ("J&J"), pursuant to which the Company shall continue to serve as J&Js vendor and partner in China, extending the long-standing cooperation between the Company and J&J in medical research, medical training and education, and brand building since 2017.

  • 04 Zhongchao Inc. Joined Hands with Professional Non-Profit Organizations and 9 Leading Pharma Companies to Carry Out Multi-Year Online Education Project on Diagnosis and Treatment of Primary Liver Cance

    Shanghai, China, July 23, 2020 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it joined hands with China Association of Health Promotion and Education (“CAHPE”), the Liver Cancer Committee of Chinese Anti-Cancer Association (“CACA”), and 9 leading pharmaceutical companies, including Roche (China) Co., Ltd., Bayer (China) Limited, Eisai China Inc., Merck (China) Ltd., Jiangsu Hengrui Medicine Co., Ltd.,  Innovent Biologics, Inc., Junshi Biosciences, Gilead Sciences Shanghai Pharmaceutical Technology Co., Ltd., and BeiGene, Ltd., to carry out a multi-year online education project on the diagnosis and treatment of primary liver cancer (the “Project”).

More